Articles dans des revues avec comité de lecture (60)
  1. 21. Tosolini, M., Pont, F., Poupot, M., Vergez, F., Nicolau-Travers, M. L., Vermijlen, D., Sarry, J. E., Dieli, F., & Fournié, J.-J. (2017). Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays. Oncoimmunology, 6(3), e1284723. doi:10.1080/2162402X.2017.1284723
  2. 22. van Caeneghem, Y., Kerre, T., Debets, R., Vermijlen, D., Abken, H., Vandekerckhove, B., De Munter, S., Tieppo, P., Goetgeluk, G., Weening, K., Verstichel, G., Bonte, S., Taghon, T., & Leclercq, G. (2017). Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology, 6(3), e1283460. doi:10.1080/2162402X.2017.1283460
  3. 23. Verstichel, G., Vermijlen, D., Martens, L., Goetgeluk, G., Brouwer, M., Thiault, N., van Caeneghem, Y., De Munter, S., Weening, K., Bonte, S., Leclercq, G., Taghon, T., Kerre, T., Saeys, Y., Van Dorpe, J., Cheroutre, H., & Vandekerckhove, B. (2017). The checkpoint for agonist selection precedes conventional selection in human thymus. Science immunology, 2, eaah4232. doi:10.1126/sciimmunol.aah4232
  4. 24. Van Hede, D., Polese, B., Humblet, C., Wilharm, A., Renoux, V., Dortu, E., de Leval, L., Delvenne, P., Desmet, C., Bureau, F., Jacobs, N., & Vermijlen, D. (2017). Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation. Proceedings of the National Academy of Sciences of the United States of America, 114(43), E9056-E9065. doi:10.1073/pnas.1712883114
  5. 25. Roger, T., Schlapbach, L. L., Schneider, A., Weier, M., Wellmann, S., Marquis, P., Vermijlen, D., Sweep, F. C. G. J. F., Leng, L., Bucala, R., Calandra, T., & Giannoni, E. (2017). Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life. Frontiers in immunology, 8, 26. doi:10.3389/fimmu.2017.00026
  6. 26. Khairallah, C., Netzer, S., Villacreces, A., Juzan, M., Rousseau, B., Dulanto Magallanes, S. A., Giese, A., Costet, P., Praloran, V., Moreau, J. F., Dubus, P., Vermijlen, D., Dechanet-Merville, J., & Capone, M. (2015). γδ T Cells Confer Protection against Murine Cytomegalovirus (MCMV). P L o S Pathogens, 11(3), e1004702, 1-22. doi:10.1371/journal.ppat.1004702
  7. 27. Dimova, T., Brouwer, M., Gosselin, F., Tassignon, J., Leo, O., donner, C., Marchant, A., & Vermijlen, D. (2015). Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proceedings of the National Academy of Sciences of the United States of America, 112(6), E556-E565. doi:10.1073/pnas.1412058112/-/DCSupplemental
  8. 28. Vermijlen, D., Braun, M. Y., & Marchant, A. (2014). Do PI3-kinase mutations drive T cells insane? Cellular & Molecular Immunology, 11(4), 320-322. doi:10.1038/cmi.2014.11
  9. 29. Huygens, A., Dauby, N., Vermijlen, D., & Marchant, A. (2014). Immunity to cytomegalovirus in early life. Frontiers in immunology, 5, 552. doi:10.3389/fimmu.2014.00552
  10. 30. Vermijlen, D., & Prinz, I. (2014). Ontogeny of Innate T Lymphocytes - Some Innate Lymphocytes are More Innate than Others. Frontiers in immunology, 5, 486. doi:10.3389/fimmu.2014.00486
  11. 31. Scheper, W., van Dorp, S., Kersting, S., Pietersma, F., Lindemans, C., Hol, S., Heijhuurs, S., Sebestyen, Z., Gründer, C., Marcu-Malina, V., Marchant, A., donner, C., Plachter, B., Vermijlen, D., van Baarle, D., & Kuball, J. (2013). γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia, 27(6), 1328-1338. doi:10.1038/leu.2012.374
  12. 32. Moens, E., Brouwer, M., Dimova, T., Goldman, M., Willems, F., & Vermijlen, D. (2011). IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17. Journal of leukocyte biology, 89(5), 743-752. doi:10.1189/jlb.0910501
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>